Zaloguj się

Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus (AAV) Capsid Variants

4.3K Views

09:20 min

October 18th, 2022

DOI :

10.3791/64389-v

October 18th, 2022


Przeglądaj więcej filmów

Next generation Gene Therapy

Rozdziały w tym wideo

0:05

Introduction

1:16

Analysis of the AAV Viral Library (In Vitro) by NGS

3:42

Analysis of AAV Viral Library (In Vivo) by NGS

7:08

Results: Peptide Display AAV Capsid Engineering and Barcoded AAV Library Screening for Isolation of Next-Generation Gene Therapy Vectors

8:36

Conclusion

Powiązane Filmy

article

10:03

Transplantation of Induced Pluripotent Stem Cell-derived Mesoangioblast-like Myogenic Progenitors in Mouse Models of Muscle Regeneration

9.4K Views

article

13:31

Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis

8.7K Views

article

07:09

Isolation of Murine Adipose Tissue-derived Microvascular Fragments as Vascularization Units for Tissue Engineering

12.3K Views

article

11:53

Predicting Gene Silencing Through the Spatiotemporal Control of siRNA Release from Photo-responsive Polymeric Nanocarriers

7.2K Views

article

11:28

3D Microtissues for Injectable Regenerative Therapy and High-throughput Drug Screening

10.2K Views

article

07:36

Studying Cavitation Enhanced Therapy

5.1K Views

article

09:20

Reliably Engineering and Controlling Stable Optogenetic Gene Circuits in Mammalian Cells

2.3K Views

article

07:28

Photodegradable Hydrogel Interfaces for Bacteria Screening, Selection, and Isolation

2.7K Views

article

08:27

Quantification of Oculomotor Responses and Accommodation Through Instrumentation and Analysis Toolboxes

814 Views

article

11:30

Automating Citrus Budwood Processing for Downstream Pathogen Detection Through Instrument Engineering

683 Views

JoVE Logo

Prywatność

Warunki Korzystania

Zasady

Badania

Edukacja

O JoVE

Copyright © 2025 MyJoVE Corporation. Wszelkie prawa zastrzeżone